Losartan vs ace inhibitors
Pro Research Analysisby 
Searched over 200M research papers
Pharmacological Differences Between Losartan and ACE Inhibitors
Losartan is an angiotensin II receptor blocker (ARB) that works by selectively blocking the AT1 receptor, while ACE inhibitors block the conversion of angiotensin I to angiotensin II and also affect other substrates like kinins. This difference means ACE inhibitors can cause side effects such as cough due to kinin accumulation, which losartan does not cause. Additionally, losartan blocks angiotensin II effects regardless of how it is formed, while ACE inhibitors may not fully block angiotensin II produced by non-ACE pathways. Both drug classes are effective in lowering blood pressure and treating heart failure, but their side effect profiles differ due to these mechanisms Siegl1995Lacourciére1994.
Efficacy in Hypertension and Heart Failure
Studies show that losartan and ACE inhibitors have similar efficacy in treating hypertension and in preventing complications such as kidney dysfunction, cardiac hypertrophy, and stroke in animal models. In heart failure, large clinical trials have found that losartan is not superior to ACE inhibitors like captopril in reducing mortality or improving survival. Both drug classes are effective, but ACE inhibitors remain the first-line treatment for heart failure due to slightly better outcomes in some studies Siegl1995Dickstein2002Pitt2000+1 MORE.
Tolerability and Side Effects: Cough and Discontinuation Rates
A key difference between losartan and ACE inhibitors is the incidence of cough. ACE inhibitors are well known to cause cough in some patients, while losartan has a much lower risk of this side effect. In patients who developed cough with ACE inhibitors, switching to losartan resulted in significantly fewer complaints of cough, making losartan a good alternative for those who cannot tolerate ACE inhibitors due to this issue. Additionally, studies have shown that losartan is generally better tolerated, with fewer patients discontinuing treatment due to adverse effects compared to ACE inhibitors Pitt2000Lacourciére1994.
Use After Myocardial Infarction
In high-risk patients after acute myocardial infarction, ACE inhibitors have a slight advantage over losartan in reducing all-cause mortality, although the difference is not statistically significant. Losartan is better tolerated, but current evidence suggests ACE inhibitors should remain the first choice after complicated myocardial infarction. Losartan can be considered for patients who are intolerant to ACE inhibitors .
Combination Therapy: Losartan Plus ACE Inhibitors
Adding losartan to an ACE inhibitor in patients with mild to moderate heart failure who are already maximally treated with an ACE inhibitor does not provide additional benefits in exercise capacity, quality of life, or hemodynamics. The combination is well tolerated, but does not offer substantial advantages over ACE inhibitor therapy alone .
Renal Effects and Safety in Renal Dysfunction
Both losartan and ACE inhibitors can cause renal dysfunction, especially in patients with conditions like bilateral renal artery stenosis or severe heart failure. The risk of renal toxicity appears to be similar for both drug classes, and there is no strong evidence that losartan is safer than ACE inhibitors in patients with or without underlying renal dysfunction. Renal function should be closely monitored when using either drug in at-risk patients .
Risk of Pneumonia
A large cohort study found that losartan is associated with a lower risk of hospitalization for pneumonia and pneumonia-related mortality compared to several ACE inhibitors. This suggests a potential safety advantage for losartan in this specific context .
Effects on ACE2 Expression
Research in animal models indicates that ACE inhibitors like lisinopril can increase tissue levels of ACE2, the receptor for SARS-CoV-2, while losartan does not have this effect. The clinical significance of this finding is still being studied, especially in the context of COVID-19 .
Conclusion
Losartan and ACE inhibitors are both effective for hypertension and heart failure, but differ in their mechanisms, side effect profiles, and tolerability. ACE inhibitors remain the first-line therapy for heart failure and post-myocardial infarction, but losartan is a valuable alternative for patients who cannot tolerate ACE inhibitors, particularly due to cough. Both drugs require careful monitoring in patients with renal dysfunction, and losartan may offer some advantages in terms of pneumonia risk and overall tolerability.
Sources and full results
Most relevant research papers on this topic
Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: a nationwide cohort study
ACE inhibitors are not associated with a lower risk of pneumonia incidence and mortality compared to losartan.
Losartan as an Alternative to ACE Inhibitors in Patients with Renal Dysfunction
Losartan may be used as an alternative to ACE inhibitors in patients with renal dysfunction, but monitoring renal function is crucial due to potential negative effects.
DOI